SNG — Synairgen Share News
0.000.00%
Refinitiv Newscasts - UK Day Ahead: Staycations to boost Intercontinental Group's full year revenues
Brief: Synairgen Plc Announces Topline Results From Phase 3 Sprinter Trial
Synairgen set for worst day after inhalable drug fails COVID study
Synairgen's inhalable drug fails study in hospitalised COVID patients (updated)
UK Stocks-Factors to watch on Feb 21 (updated)
Synairgen's inhalable drug fails study in hospitalised COVID patients
Topline results from Phase 3 SPRINTER trial
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Brief: Synairgen Announces Partnership With Ashfield
Synairgen announces partnership with Ashfield
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Data Presented at ESWI Influenza Conference
Holding(s) in Company